Milan, Italy

Clara Torricelli

This inventor holds 1 USPTO granted patent. Top assignee: Farmitalia Carlo Erba S.r.l.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clara Torricelli. Retrieved from https://idiyas.com/inventor/clara-torricelli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Clara Torricelli and Pharmaceutical Composition Innovation.

Introduction

Clara Torricelli is an inventor associated with Milan, Italy, and pharmaceutical research at Farmitalia Carlo Erba S.r.l. Her patent work concerns improving the dissolution properties of pharmaceutical compositions.

Latest Patents

The provided information lists one patent for Torricelli: “Pharmaceutical Compositions Having Improved Dissolution Properties.” The invention describes a pharmaceutical composition containing a drug and dehydrated cyclodextrin, along with a process for preparing the composition. The patent’s stated aim is to improve the drug’s dissolution properties.

Career Highlights

Torricelli’s listed patent reflects work on pharmaceutical formulation and the use of cyclodextrins in drug compositions. The available information identifies her as an inventor associated with Farmitalia Carlo Erba S.r.l. in Milan.

Collaborations

Torricelli’s named coworkers include Carlo Confalonieri and Roberto De Ponti.

Conclusion

Clara Torricelli’s documented contribution is a pharmaceutical-composition patent focused on improving dissolution through the use of dehydrated cyclodextrin.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…